Express Pharma
Home  »  Archive  »  Jubilant Clinsys launches TrialStat eClinical Suite

Jubilant Clinsys launches TrialStat eClinical Suite

0 19

TrialStat, the technology division of Jubilant Clinsys, a full service global Contract Research Organization (CRO) and a subsidiary of Jubilant Life Sciences has launched TrialStat eClinical Suite.

TrialStat Orbit is an electronic data capture solution used by a wide range of pharmaceutical and CRO customers worldwide, being utilised for complex Phase II and III studies. ORBIT was the industry’s first EDC platform to allow all aspects of a study to be configured, deployed and managed through a browser interface, enabling customers to start their studies quickly and cost-effectively. Orbit also includes advanced integrated features such as IWR, Imaging, Coding and Electronic Patient Access. It has been successfully deployed in over 350 global studies.

TrialStat CTMS is a Clinical Trial Management System designed to be fully integrated with Orbit, allowing for data entered into Orbit to trigger actions in the CTMS, thereby increasing visibility for critical management areas such as patient enrolment, monitoring management, and site payments. TrialStat Portal is a central database designed to provide seamless integration with all TrialStat products creating the ultimate study management tool through real-time visualisation of your study data. The portal can be accessed by study sites, Sponsors and CROs for central communication and critical decision making.

Nayan Nanavati, Chief Executive Officer, Jubilant Clinsys said, “TrialStat eClinical Suite is an innovative cloud-based platform providing an advanced set of features with a strong focus on usability enabling the power to manage your trial efficiently and providing our clients’ a robust platform for improving data collection and study management.”

This eClinical suite uses the latest in today’s technology to revolutionise and redefine integrated clinical software.

EP News BureauMumbai

Leave A Reply

Your email address will not be published.